Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, United States.
Preclinical Pharmacology Core, Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, United States.
Elife. 2021 Dec 7;10:e71502. doi: 10.7554/eLife.71502.
Serine ADP-ribosylation (ADPr) is a DNA damage-induced post-translational modification catalyzed by the PARP1/2:HPF1 complex. As the list of PARP1/2:HPF1 substrates continues to expand, there is a need for technologies to prepare mono- and poly-ADP-ribosylated proteins for biochemical interrogation. Here, we investigate the unique peptide ADPr activities catalyzed by PARP1 in the absence and presence of HPF1. We then exploit these activities to develop a method that facilitates installation of ADP-ribose polymers onto peptides with precise control over chain length and modification site. Importantly, the enzymatically mono- and poly-ADP-ribosylated peptides are fully compatible with protein ligation technologies. This chemoenzymatic protein synthesis strategy was employed to assemble a series of full-length, ADP-ribosylated histones and show that ADPr at histone H2B serine 6 or histone H3 serine 10 converts nucleosomes into robust substrates for the chromatin remodeler ALC1. We found ALC1 preferentially remodels 'activated' substrates within heterogeneous mononucleosome populations and asymmetrically ADP-ribosylated dinucleosome substrates, and that nucleosome serine ADPr is sufficient to stimulate ALC1 activity in nuclear extracts. Our study identifies a biochemical function for nucleosome serine ADPr and describes a new, highly modular approach to explore the impact that site-specific serine mono- and poly-ADPr have on protein function.
丝氨酸 ADP-核糖基化(ADPr)是一种由 PARP1/2:HPF1 复合物催化的 DNA 损伤诱导的翻译后修饰。随着 PARP1/2:HPF1 底物列表的不断扩展,需要有技术来制备单聚和多聚 ADP-核糖基化蛋白,以便进行生化研究。在这里,我们研究了 PARP1 在没有 HPF1 的情况下和存在 HPF1 的情况下催化的独特肽 ADPr 活性。然后,我们利用这些活性开发了一种方法,可在精确控制链长和修饰位点的情况下,将 ADP-核糖聚合物安装到肽上。重要的是,酶促单聚和多聚 ADP-核糖基化肽完全兼容蛋白质连接技术。这种化学酶促蛋白质合成策略被用于组装一系列全长、ADP-核糖基化的组蛋白,并表明组蛋白 H2B 丝氨酸 6 或组蛋白 H3 丝氨酸 10 的 ADPr 将核小体转化为染色质重塑酶 ALC1 的强底物。我们发现 ALC1 优先重塑异质单核小体群体和不对称 ADP-核糖基化二核小体底物中的“激活”底物,并且核小体丝氨酸 ADPr 足以刺激核提取物中的 ALC1 活性。我们的研究确定了核小体丝氨酸 ADPr 的生化功能,并描述了一种新的、高度模块化的方法来研究特定丝氨酸单聚和多聚 ADPr 对蛋白质功能的影响。